Takashi Nakahara Selected Research

Takashi Nakahara Research Topics

Disease

60	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2012
24	Fibrosis (Cirrhosis) 03/2024 - 07/2013
21	Neoplasms (Cancer) 11/2023 - 08/2012
18	Infections 01/2023 - 11/2013
16	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 06/2015
16	Chronic Hepatitis C 01/2021 - 12/2014
11	Non-alcoholic Fatty Liver Disease 01/2023 - 02/2014
8	Liver Diseases (Liver Disease) 01/2023 - 02/2014
7	Hepatic Encephalopathy 09/2023 - 07/2013
7	Chronic Hepatitis B 01/2021 - 01/2016
6	Neoplasm Metastasis (Metastasis) 11/2023 - 10/2018
6	Inflammation (Inflammations) 01/2023 - 04/2010
5	Hepatitis B 01/2023 - 03/2017
5	Thrombosis (Thrombus) 04/2021 - 06/2015
5	Disease Progression 04/2020 - 04/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2018
3	Sarcopenia 02/2020 - 10/2018
3	Dyslipidemias (Dyslipidemia) 08/2019 - 11/2012
3	Hemorrhage 01/2018 - 11/2015
2	Portal Hypertension 03/2024 - 11/2020
2	Hypertension (High Blood Pressure) 11/2023 - 08/2019
2	Proteinuria 11/2023 - 08/2023
2	Acute-On-Chronic Liver Failure 10/2023 - 10/2023
2	Acute Liver Failure (Fulminant Hepatic Failure) 09/2023 - 12/2017
2	Post-Cardiac Arrest Syndrome 01/2023 - 01/2015
2	Insulin Resistance 03/2022 - 02/2014
2	Alcoholic Fatty Liver 07/2021 - 11/2012
2	Hepatitis 01/2021 - 12/2018
2	Wounds and Injuries (Trauma) 01/2021 - 11/2015
2	Necrosis 01/2021 - 01/2018
2	Microsatellite Instability 10/2020 - 07/2020
2	Hepatitis C 09/2020 - 12/2014
2	Edema (Dropsy) 02/2020 - 08/2016
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 12/2018
2	Lymphatic Metastasis 08/2019 - 08/2012

Drug/Important Bio-Agent (IBA)

21	lenvatinibIBA 11/2023 - 01/2019
13	Antiviral Agents (Antivirals)IBA 01/2023 - 08/2016
13	InterferonsIBA 11/2020 - 07/2013
12	Bevacizumab (Avastin)FDA Link 03/2024 - 08/2021
12	atezolizumabIBA 03/2024 - 08/2021
12	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2012
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2018
8	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 12/2014
6	CytokinesIBA 09/2023 - 01/2009
6	Proteins (Proteins, Gene)FDA Link 08/2023 - 12/2009
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2014
6	Hemoglobins (Hemoglobin)IBA 01/2023 - 05/2009
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 12/2017
6	AntigensIBA 01/2021 - 11/2016
6	asunaprevirIBA 01/2020 - 08/2016
6	daclatasvirIBA 01/2020 - 08/2016
5	Alanine Transaminase (SGPT)IBA 01/2023 - 03/2014
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 03/2017
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2014
5	SofosbuvirIBA 11/2020 - 06/2017
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2024 - 05/2016
4	NucleotidesIBA 01/2023 - 01/2018
4	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2017
4	regorafenibIBA 01/2021 - 09/2018
3	nasIBA 03/2024 - 06/2020
3	Interleukin-6 (Interleukin 6)IBA 10/2023 - 12/2009
3	Interleukin-8 (Interleukin 8)IBA 09/2023 - 12/2009
3	Prothrombin (Factor II)IBA 09/2023 - 12/2017
3	BilirubinIBA 08/2023 - 12/2017
3	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 08/2012
3	EnzymesIBA 02/2021 - 10/2019
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 11/2016
3	Fetal Proteins (Fetoprotein)IBA 11/2020 - 01/2012
3	NucleosidesIBA 01/2019 - 01/2018
3	HMGB1 Protein (HMG1)IBA 01/2018 - 12/2009
2	Alkaline PhosphataseIBA 03/2024 - 10/2019
2	CreatinineIBA 08/2023 - 08/2016
2	AlbuminsIBA 08/2023 - 10/2019
2	Therapeutic UsesIBA 01/2023 - 07/2021
2	LipidsIBA 01/2023 - 11/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 11/2012
2	Carrier Proteins (Binding Protein)IBA 01/2022 - 09/2020
2	Immune Checkpoint InhibitorsIBA 02/2021 - 10/2020
2	glecaprevir and pibrentasvirIBA 01/2021 - 01/2020
2	pembrolizumabIBA 10/2020 - 07/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2020 - 01/2009
2	pibrentasvirIBA 04/2020 - 03/2019
2	glecaprevirIBA 04/2020 - 03/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2018
2	AmmoniaIBA 08/2019 - 01/2019
2	ChemokinesIBA 07/2019 - 01/2018
2	ledipasvirIBA 12/2018 - 11/2017
2	entecavir FDA Link 12/2018 - 01/2018

Therapy/Procedure

52	Therapeutics 03/2024 - 11/2010
12	Drug Therapy (Chemotherapy) 06/2022 - 08/2012
8	Radiotherapy 01/2023 - 08/2012
5	Liver Transplantation 09/2023 - 03/2017
3	Hepatectomy 01/2022 - 08/2012
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2019 - 07/2013
3	Resuscitation 10/2016 - 01/2015
2	Aftercare (After-Treatment) 10/2023 - 01/2023
2	Cardiopulmonary Resuscitation (CPR) 01/2023 - 11/2015
2	Induced Hypothermia 01/2023 - 01/2015
2	Bariatric Surgery 01/2022 - 07/2021